| Description | Isojacareubin displays potent activity against H. pylori HP40 clinical isolate with MIC 23.9 uM, which is approximately two times greater than that of the standard drug amoxicillin. Isojacareubin is a potent inhibitor of protein kinase C (PKC), suppresses hepatocellular carcinoma metastasis and induces apoptosis in vitro and in vivo, thus, it as a promising lead compound for the development of new antihepatoma agents. |
| molecular weight | 326.304 |
| Molecular formula | C18H14O6 |
| CAS | 50597-93-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |